mHealth Intelligence October 12, 2018
The FDA has granted market clearance to the FibriCheck mHealth app, which measures heart rhythm via a smartphone camera or smartwatch sensors and can be used to detect atrial fibrillation.
Federal officials have OK’d the first mHealth app capable of detecting atrial fibrillation.
The U.S. Food and Drug Administration recently granted market clearance for FibriCheck, a Belgium-based company whose mobile health app uses a smartphone camera or smartwatch sensors to measure one’s heartbeat. The process, called photoplethysmography, measures light reflection through blood flow.
FDA officials said this is the first approved mHealth app that detects heart rhythm disorders using only an optical signal originating from a non-medical device.
Today's Sponsors
Today's Sponsor